DIN 02047535 — ORFENACE TABLET 100MG 100 MG
ORFENACE TABLET 100MG is a tablet of Orphenadrine marketed by STERIMAX INC. The full Orphenadrine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02047535
- Brand name
- ORFENACE TABLET 100MG
- Active ingredient
- Orphenadrine
- Strength
- 100 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- STERIMAX INC
- Health Canada status
- DORMANT
- Drug class
- Centrally acting skeletal muscle relaxant with antimuscarinic (anticholinergic) activity
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Orphenadrine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02229731 | ORPHENADRINE CITRATE INJECTION, USP | 30 MG | LIQUID | STERIMAX INC | DORMANT |
| 02243559 | SANDOZ ORPHENADRINE | 100 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |